Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Tusamitamab Ravtansine vs Docetaxel in CEACAM5+ NSCLC Sep 11, 2024
Lung Cancer,SCLC (Small Cell Lung Cancer) Tarlatamab + PD-L1 Inhibitor as 1LM in ES-SCLC: DeLLphi-303 Sep 11, 2024
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Efficacy of Lazertinib vs Osimertinib in 1L EGFR NSCLC Sep 11, 2024
Genitourinary Cancer,Prostate Cancer Safety & Efficacy of Imidafenacin for Post-RARP Incontinence Sep 11, 2024
CLL (Chronic Lymphocytic Leukemia),DLBCL (Diffuse Large B Cell Lymphoma),Leukemia,Lymphoma Safety and Efficacy of Pirtobrutinib in Richter Transformation Sep 11, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Chidamide + R-GDP Shows Promise in Patients With R/R DLBCL Sep 11, 2024
